Search

everythinglearnresearchcommunity

for

Search:↓

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Dissolving microneedles show promise for treating hair loss but need more research for practical use.

Abrocitinib may effectively treat stubborn alopecia universalis.

Plant-based nanovesicles effectively deliver finasteride for hair regrowth in androgenetic alopecia.

The treatment using a special hydrogel shows promise for promoting hair growth.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Future research on female pattern hair loss should focus on treatment effectiveness, safety, and understanding causes.

Korean patients with rosacea are more likely to have other health conditions.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

The COVID-19 vaccine is viewed more negatively and causes more side effects than the flu vaccine in Korean patients with lupus.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

The guidelines recommend effective systemic treatments for alopecia areata in Korea.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Higher inflammation markers are linked to more severe alopecia areata.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Chronic scarring alopecia is common in SLE patients and needs early detection and management.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Early hair loss may indicate higher risk of diabetes and heart disease.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Minoxidil helps hair regrowth in alopecia areata safely.

Topical minoxidil can cause serious heart issues in children.